Our trainers are active practitioners, skilled in imparting knowledge on successfully building entreprenuership, technology transfer, knowledge exchange and research commercialisation activity
We have a wide community of trainers on which to call, all of premium calibre, some of whom are profiled below.
For any queries regarding PraxisAuril's International work, contact firstname.lastname@example.org or +44 (0)1223 659961
Top row: Dr Nessa Carey, RTTP; Dr Phil Clare, RTTP; Maureen Kelly, RTTP; Robert Marshall;
Bottom row: Dr David Secher, RTTP; Dr Alison Campbell, RTTP; Dr Malcolm Skingle RTTP, Richard Brooks
Dr Nessa Carey
Nessa is a Registered Technology Transfer Professional (RTTP) and joined PraxisUnico a International Director in 2014. Prior to this she spent 13 successful years in senior positions in the biotechnology and pharmaceutical sectors, with roles including Senior Director in External Research and Development Innovation at Pfizer, Director of Research at CellCentric and Head of Biology at TopoTarget. In these positions she gained extensive experience in what industry seeks from academia, in contexts ranging from start-ups to multinational corporations. Prior to this, Nessa was a Senior Lecturer at Imperial College London, where she is now a Visiting Professor. Her academic background means that she understands the drivers and difficulties in knowledge transfer for both the academic and industrial communities. She also holds advisory positions with a number of UK research funding agencies.
Nessa is highly experienced in the fields of communication and training. In addition to her academic teaching, she has a wealth of experience as a trainer, which has included delivering courses for Imperial College School of Medicine and the Royal College of Surgeons (UK and Ireland).
Richard Brooks is a former non-executive director of PraxisAuril and co-founder of Flexible Directors, which has provided flexible Finance Directors on a part-time or interim basis for 23 years and helps organisations across many sectors - including technology, food, retail, manufacturing and not-for-profit - overcome their barriers to growth. He is an investor in start-up technology businesses and since 2009 has been on the finance and tax committee of the Bio Industry Association.
He is a presenter on entrepreneurship workshops for engineers and physicists in developing countries, organised worldwide by the Institute of Physics. In 2014 he also presented on the Science Technology and Engineering for Development workshop in Islamabad organised by the US State Department.
Dr Alison Campbell
Alison is Director of Knowledge Transfer Ireland (KTI). KTI is a national resource, responsible for the promotion, development and management of Ireland’s knowledge transfer system.
With over 20 years working at the academic-industry interface, Alison's experience includes business development and industry collaboration, IP management, out-licensing, start-up company creation, executive education, policy and the impact of research and innovation. During her career, she has worked in the biotech industry, led technology transfer and research support offices and worked as an independent consultant specialising in technology transfer and open innovation.
Alison is a former non-executive director of PraxisAuril and Portfolio Chair for International Development. She is also a former Director of the global Alliance of Technology Transfer Professionals (ATTP) and a Registered Technology Transfer Professional (RTTP). Alison has served as a non-executive director on a number of companies and acted as an advisor to government departments in the UK and overseas. She was awarded an OBE for her services to UK knowledge transfer in 2010.
Dr Phil Clare
Phil is a member of the HEFCE Research and Knowledge Exchange Committee of Council and a board member of PraxisAuril. He is a registered technology transfer professional (RTTP). Phil is Associate Director of Research Services and Head of Knowledge Exchange at the University of Oxford. Research Services supports all aspects of research strategy and negotiates and administers research grants and contracts. The team is also responsible for research ethics and integrity, clinical trials governance, IP rights due diligence and related Knowledge Exchange activities. This includes developing new ways for the University to work with industry and coordinating knowledge exchange activity across the university. Phil is responsible for the Knowledge Exchange and Impact Team (KEIT) and the Intellectual Property Rights Management Team, negotiating some strategic contracts and working closely with Isis Innovation Ltd, the University’s wholly-owned technology transfer company.
Maureen is an experienced intellectual property and information technology solicitor with Keystone Law. She is a registered technology transfer professional (RTTP) and works across a wide variety of sectors including healthcare, technology, education, travel, media and entertainment. Amongst other things she specialises in facilitating knowledge transfer between research organisations and industry. She has been planning, negotiating, drafting and closing technology transfer deals for 20 years with a particular focus on research collaborations and licences.
Prior to joining Keystone, Maureen spent 10 years with a London City law firm and three years as an in-house solicitor with Cancer Research Technology, the technology transfer company of Cancer Research UK. Maureen has enjoyed working as a trainer for PraxisAuril since 2004. She has designed, directed and provided training on numerous courses.
After more than two decades working at a senior level in the university sector and manufacturing management, Robert Marshall now provides training, consultancy, personal coaching and advice on technology transfer, commercial negotiation, conflict resolution and communications for a wide range of private and public sector clients worldwide. He is passionately interested in the psychology of the workplace, negotiation and dispute resolution.
Robert was Head of Technology Transfer at the University of Cambridge, where he was instrumental in the creation and development of the Technology Transfer Office (now called Cambridge Enterprise). For four years he was Director of Research & Business Services at the University of East Anglia (UK), and before that he worked in manufacturing management, consultancy, research management and as a quality manager in specialist engineering companies.
He is a former member of the Bank of England’s Consultative Group and has served on the governing council of The Association for University Research and Industry Links (AURIL).
Dr David Secher
In 2002, together with Lita Nelsen of MIT, David Secher founded Praxis (now PraxisAuril). He has served as chairman or as a director at PraxisUnico since then and in September 2012 became one of our Patrons. David is a Registered Technology Transfer Professional (RTTP). David Secher is an independent consultant in the areas of research commercialisation, intellectual property and technology transfer in the UK and internationally. Recent assignments include work in Japan, Saudi Arabia, Brazil, Chile, Lebanon, Jordan, Mexico and Europe. As a consultant, he has advised universities, governments and individuals on commercialisation of intellectual property, as well as acting as a non-executive director of high technology and investment companies.
David is based in the University of Cambridge and is a Life Fellow and Senior Bursar of Gonville and Caius College.
Previous roles include Chief Executive of the N8 Research Partnership (a collaboration of the eight most research-intensive universities in the North of England); Director of Research Services, University of Cambridge; Director of Drug Development, Cancer Research Campaign (now Cancer Research UK); and Director of Monoclonal Therapeutics, Celltech Ltd. His PhD work at the Medical Research Council (MRC) Laboratory of Molecular Biology was with the late César Milstein (Nobel Prize-winner for discovery of monoclonal antibodies). Together with Derek Burke, David made and patented the first monoclonal antibody to human interferon.
David was awarded the Queen's Award for Enterprise Promotion in 2007, in recognition of his contributions to creating "environments that favour enterprise, specialising in the practical aspects of commercialising the results of academic research".
Dr Malcolm Skingle
Malcolm is a former director of PraxisUnico and chaired its Industry Engagement Committee. He has an exceptional breadth of experience in the management of research activities and has authored more than 60 publications including articles on the interface between industry and academia.
Malcolm has managed Academic Liaison at GlaxoSmithKline for more than twenty years, leading staff in the UK and US. His role involves close liaison with several groups outside the company e.g. government departments, Research and Funding Councils, small biotechnology companies and other science-driven organisations. He sits on many external bodies and several UK University Department advisory groups and he sat on the 2014 Research Excellence Framework (REF) Main Panel A. He also chairs several groups including the Diamond (Synchrotron) Industrial Advisory Board, the Science Industry Partnership skills initiative and the ABPI group working on academic liaison.
Malcolm was awarded a CBE in the 2009 Queen's Birthday Honours List in recognition of his contribution to the pharmaceutical industry as well as an Honorary Professorship from the College of Medical and Dental Sciences at the University of Birmingham and an honorary DSc from the University of Hertfordshire.